Yan Tang

2.0k total citations · 1 hit paper
33 papers, 1.4k citations indexed

About

Yan Tang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Yan Tang has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Yan Tang's work include Tuberous Sclerosis Complex Research (7 papers), Nanoplatforms for cancer theranostics (4 papers) and Renal cell carcinoma treatment (3 papers). Yan Tang is often cited by papers focused on Tuberous Sclerosis Complex Research (7 papers), Nanoplatforms for cancer theranostics (4 papers) and Renal cell carcinoma treatment (3 papers). Yan Tang collaborates with scholars based in United States, China and Saudi Arabia. Yan Tang's co-authors include Tiegang Han, Moustafa R. K. Ali, Mostafa A. El‐Sayed, Yue Wu, Elizabeth P. Henske, Haopeng Xiao, Ronghu Wu, Jason Evans, Zhongfeng Ye and Qiaobing Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Yan Tang

28 papers receiving 1.4k citations

Hit Papers

Lung-selective mRNA delivery of synthetic lipid nanoparti... 2022 2026 2023 2024 2022 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis
    2022 358 citations Yan Tang, Elizabeth P. Henske et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Tang United States 14 630 519 251 247 217 33 1.4k
Dickson Kirui United States 15 447 0.7× 475 0.9× 406 1.6× 120 0.5× 102 0.5× 21 1.1k
Hualin Fu China 26 889 1.4× 561 1.1× 231 0.9× 152 0.6× 139 0.6× 46 1.9k
Qingjie Ma China 17 402 0.6× 1.2k 2.2× 494 2.0× 157 0.6× 272 1.3× 40 1.7k
Yuanwei Pan China 26 592 0.9× 1.2k 2.3× 430 1.7× 143 0.6× 251 1.2× 63 1.9k
Aman P. Mann United States 14 732 1.2× 515 1.0× 347 1.4× 52 0.2× 308 1.4× 21 1.7k
Adam Yuh Lin United States 15 377 0.6× 454 0.9× 238 0.9× 131 0.5× 79 0.4× 39 988
Tao Tan China 22 1.1k 1.7× 1.3k 2.4× 621 2.5× 125 0.5× 181 0.8× 64 2.5k
Wei Tian China 16 286 0.5× 685 1.3× 302 1.2× 89 0.4× 133 0.6× 44 1.2k
Carolin Bier Germany 16 804 1.3× 259 0.5× 469 1.9× 100 0.4× 99 0.5× 23 1.4k
Blanca Ocampo‐García Mexico 25 429 0.7× 462 0.9× 513 2.0× 91 0.4× 452 2.1× 97 1.8k

Countries citing papers authored by Yan Tang

Since Specialization
Citations

This map shows the geographic impact of Yan Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Tang more than expected).

Fields of papers citing papers by Yan Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Tang. The network helps show where Yan Tang may publish in the future.

Co-authorship network of co-authors of Yan Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Tang. A scholar is included among the top collaborators of Yan Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Tang. Yan Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuya, Yifei Ren, Qinglv Wei, et al.. (2025). hnRNPL phase separation activates PIK3CB transcription and promotes glycolysis in ovarian cancer. Nature Communications. 16(1). 4828–4828.
2.
Khabibullin, Damir, Tiegang Han, Yan Tang, et al.. (2025). Targeting KIT With Antibody-Drug Conjugates in Chromophobe Renal Cell Carcinoma. Clinical Genitourinary Cancer. 23(4). 102359–102359. 1 indexed citations
3.
Salem, S., Tiegang Han, Damir Khabibullin, et al.. (2025). Targeting FSP1 to induce ferroptosis in chromophobe renal cell carcinoma. Oncogene. 44(42). 4075–4086. 3 indexed citations
4.
Evans, Jilly F., Yan Tang, Alexander R. Mukhitov, et al.. (2024). The Bi-steric Inhibitor RMC-5552 Reduces mTORC1 Signaling and Growth in Lymphangioleiomyomatosis. American Journal of Respiratory Cell and Molecular Biology. 72(6). 643–652. 1 indexed citations
5.
Wang, Yizhi, Si Chen, Yan Tang, et al.. (2024). TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC. Frontiers in Immunology. 15. 1499731–1499731. 1 indexed citations
6.
Liu, He, et al.. (2024). Humanistic Value Development Through Extracurricular Activities in Anatomical Education. International Journal of Morphology. 42(4). 1119–1124.
7.
Tang, Yan, et al.. (2023). The prognostic and immune significance of C15orf48 in pan-cancer and its relationship with proliferation and apoptosis of thyroid carcinoma. Frontiers in Immunology. 14. 1131870–1131870. 9 indexed citations
8.
He, Fang, et al.. (2023). Participation in a Medicare advanced primary care model and the delivery of high‐value services. Health Services Research. 58(6). 1266–1291. 4 indexed citations
9.
Du, Yina, Minzhe Guo, Yixin Wu, et al.. (2022). Lymphangioleiomyomatosis (LAM) Cell Atlas. Thorax. 78(1). 85–87. 10 indexed citations
10.
Tang, Yan, David J. Kwiatkowski, & Elizabeth P. Henske. (2022). Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment. Nature Communications. 13(1). 5018–5018. 35 indexed citations
11.
Fang, Hui, et al.. (2020). Evaluation of 2 Rat Models for Sepsis Developed by Improved Cecal Ligation/Puncture or Feces Intraperitoneal-Injection. Medical Science Monitor. 26. e919054–e919054. 19 indexed citations
12.
Tang, Yan, David J. Kwiatkowski, & Elizabeth P. Henske. (2020). mTORC1 hyperactivation in lymphangioleiomyomatosis leads toACE2upregulation in type II pneumocytes: implications for COVID-19. European Respiratory Journal. 57(2). 2002737–2002737. 9 indexed citations
13.
Kwiatkowski, David J., Valerie W. Rusch, Jamie E. Chaft, et al.. (2019). Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3).. Journal of Clinical Oncology. 37(15_suppl). 8503–8503. 106 indexed citations
14.
15.
Wu, Yue, Moustafa R. K. Ali, Bin Dong, et al.. (2018). Gold Nanorod Photothermal Therapy Alters Cell Junctions and Actin Network in Inhibiting Cancer Cell Collective Migration. ACS Nano. 12(9). 9279–9290. 117 indexed citations
16.
Tang, Yan, et al.. (2017). Endoscopic ultrasound in diagnosis of esophageal tuberculosis: 10-year experience at a tertiary care center. Diseases of the Esophagus. 30(8). 1–6. 27 indexed citations
17.
Tang, Yan, Marcela Horvitz‐Lennon, Walid F. Gellad, et al.. (2017). Prescribing of Clozapine and Antipsychotic Polypharmacy for Schizophrenia in a Large Medicaid Program. Psychiatric Services. 68(6). 579–586. 17 indexed citations
18.
19.
Tang, Yan, et al.. (2015). microRNA-451 inhibited cell proliferation, migration and invasion through regulation of MIF in renal cell carcinoma.. PubMed. 8(12). 15611–21. 28 indexed citations
20.
Tang, Yan, et al.. (2013). KiSS1 inhibits growth and invasion of osteosarcoma cells through inhibition of the MAPK pathway. European Journal of Histochemistry. 57(4). 30–30. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dickson Kirui Breakdown of academic impact, for papers by Hualin Fu Breakdown of academic impact, for papers by Qingjie Ma Breakdown of academic impact, for papers by Yuanwei Pan Breakdown of academic impact, for papers by Aman P. Mann Breakdown of academic impact, for papers by Adam Yuh Lin Breakdown of academic impact, for papers by Tao Tan Breakdown of academic impact, for papers by Wei Tian Breakdown of academic impact, for papers by Carolin Bier Breakdown of academic impact, for papers by Blanca Ocampo‐García
Rankless by CCL
2026